Search information about ADRs
Subscribe to newsletter
Potential liver toxicity of herbal supplement NMDA relief Exendo®
The Netherlands Pharmacovigilance Centre Lareb received two reports of liver toxicity associated with the use of herbal supplement NMDA relief Exendo®. One patient needed a liver t ...
First results of Dutch Biologic Monitor
48% of patients experienced at least one adverse drug reaction (ADR) after administration of a biological drug. ADRs most often reported were injection site reactions, followed by ...
Overview reports on Meningococcal group ACWY vaccine (Nimenrix®)
Since May 1st, 2018, all children aged 14 months in the Netherlands are vaccinated against Meningococcal type ACWY with the vaccine Nimenrix®. The Netherlands Pharmacovigilance Cen ...
ConcePTION project has been launched
Today, only about 5% of medications have adequate safety information on use in pregnant or breastfeeding women. Obtaining reliable safety information can take 20 or more years to c ...
Hair loss associated with use tioguanine (Thiosix®) for inflammatory bowel disease
Over the last five years, the Netherlands Pharmacovigilance Centre Lareb received twenty reports of hair loss by women associated with the use of tioguanine for bowel disease. For ...
More adverse drug reactions are reported for women
Women have a higher risk of adverse drug reactions (ADRs) being reported than men, even when differences in the number of drug users is taken into account. Lareb investigated this ...